MAHON PAUL A sold UTHR

October 1, 2026 · Form 4 insider transaction

MAHON PAUL A sold 880 shares of United Therapeutics Corporation at $558.30 per share, a transaction worth $491.3K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.

Direction
Disposed (sell-side)
Shares
880
Price
$558.30
Total value
$491.3K
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateOctober 1, 2026
Filing dateOctober 1, 2026
Shares owned after52,592
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025.; This transaction was executed in multiple trades at prices ranging from $558.30 to $558.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

View the original Form 4 on SEC EDGAR